An updated review of mucosal melanoma: Survival meta‑analysis
- Authors:
- Hyung Min Hahn
- Kyoung Geun Lee
- Won Choi
- Seung Hyun Cheong
- Ki Bum Myung
- Hyung Jin Hahn
-
Affiliations: Department of Plastic and Reconstructive Surgery, Ajou University School of Medicine, Suwon, Gyeonggi 16499, Republic of Korea, Department of Dermatology, College of Medicine, Konyang University, Daejeon, Chungcheongnam 35365, Republic of Korea - Published online on: May 29, 2019 https://doi.org/10.3892/mco.2019.1870
- Pages: 116-126
-
Copyright: © Hahn et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Patrick RJ, Fenske NA and Messina JL: Primary mucosal melanoma. J Am Acad Dermatol. 56:828–834. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Tacastacas JD, Bray J, Cohen YK, Arbesman J, Kim J, Koon HB, Honda K, Cooper KD and Gerstenblith MR: Update on primary mucosal melanoma. J Am Acad Dermatol. 71:366–375. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gru AA, Becker N, Dehner LP and Pfeifer JD: Mucosal melanoma: Correlation of clinicopathologic, prognostic, and molecular features. Melanoma Res. 24:360–370. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Thierauf J, Veit JA, Affolter A, Bergmann C, Grünow J, Laban S, Lennerz JK, Grünmüller L, Mauch C, Plinkert PK, et al: Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck. Melanoma Res. 25:503–509. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ragnarsson-Olding BK, Karsberg S, Platz A and Ringborg UK: Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes. Melanoma Res. 12:453–463. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu W, Li S, Zou B, Liu H and Wang S: Expressions and clinical significance of HER4 and CD44 in sinonasal mucosal malignant melanoma. Melanoma Res. 28:105–110. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SY, Kim SN, Hahn HJ, Lee YW, Choe YB and Ahn KJ: Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma. J Am Acad Dermatol. 72:1036–46.e2. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tierney JF, Stewart LA, Ghersi D, Burdett S and Sydes MR: Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 8:162007. View Article : Google Scholar : PubMed/NCBI | |
|
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker SB: Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Moher D, Liberati A, Tetzlaff J and Altman DG; PRISMA Group, : Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 6:e10000972009. View Article : Google Scholar : PubMed/NCBI | |
|
Ohashi A, Funasaka Y, Ueda M and Ichihashi M: c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res. 6:25–30. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Postow MA, Hamid O and Carvajal RD: Mucosal melanoma: Pathogenesis, clinical behavior, and management. Curr Oncol Rep. 14:441–448. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Altieri L, Wong MK, Peng DH and Cockburn M: Mucosal melanomas in the racially diverse population of California. J Am Acad Dermatol. 76:250–257. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Luna-Ortiz K, Aguilar-Romero M, Villavicencio-Valencia V, Zepeda-Castilla E, Vidrio-Morgado H, Peteuil N and Mosqueda-Taylor A: Comparative study between two different staging systems for mucosal melanomas of the Head and Neck. Med Oral Patol Oral Cir Bucal. 21:e425–e430. 2016.PubMed/NCBI | |
|
Youssef D, Vasani S, Marquess J and Cervin A: Rising incidence of head and neck mucosal melanoma in Australia. J Laryngol Otol. 131:S25–S28. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Marcus DM, Marcus RP, Prabhu RS, Owonikoko TK, Lawson DH, Switchenko J and Beitler JJ: Rising incidence of mucosal melanoma of the head and neck in the United States. J Skin Cancer. 2012:2316932012. View Article : Google Scholar : PubMed/NCBI | |
|
Abugideiri M, Patel K, Switchenko JM, Magliocca K, Buchwald ZS, Delgaudio J, Beitler JJ and Khan MK: Adjuvant radiation therapy improved local control for primary mucosal melanoma of the head and neck. Int J Radiation Oncol. 96:E384–E385. 2016. View Article : Google Scholar | |
|
Ahn HJ, Na II, Park YH, Cho SY, Lee BC, Lee GH, Koh JS, Lee YS, Shim YS, Kim YK, et al: Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck. Oral Oncol. 46:607–611. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Aiempanakit K, Chiratikarnwong K, Auepemkiate S and Sriplung H: Clinicopathologic characteristics and survival outcomes of primary mucosal melanomas: A 10-year retrospective analysis from a single tertiary medical center in Thailand. Zhonghua Pifuke Yixue Zazhi xxx. 1–3. 2018. | |
|
Ajmani GS, Liederbach E, Kyrillos A, Wang CH, Pinto JM and Bhayani MK: Adjuvant radiation and survival following surgical resection of sinonasal melanoma. Am J Otolaryngol. 38:663–667. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Amit M, Tam S, Abdelmeguid AS, Roberts DB, Raza SM, Su SY, Kupferman ME, DeMonte F and Hanna EY: Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. Cancer. 124:514–520. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
D'Angelo SP, Larkin J, Sosman JA, Lebbé C, Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, et al: Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: A pooled analysis. J Clin Oncol. 35:226–235. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Benlyazid A, Thariat J, Temam S, Malard O, Florescu C, Choussy O, Makeieff M, Poissonnet G, Penel N, Righini C, et al: Postoperative radiotherapy in head and neck mucosal melanoma: A GETTEC study. Arch Otolaryngol Head Neck Surg. 136:1219–1225. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bishop KD and Olszewski AJ: Epidemiology and survival outcomes of ocular and mucosal melanomas: A population-based analysis. Int J Cancer. 134:2961–2971. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chiu NT and Weinstock MA: Melanoma of oronasal mucosa. Population-based analysis of occurrence and mortality. Arch Otolaryngol Head Neck Surg. 122:985–988. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Ciarrocchi A, Pietroletti R, Carlei F and Amicucci G: Extensive surgery and lymphadenectomy do not improve survival in primary melanoma of the anorectum: Results from analysis of a large database (SEER). Colorectal Dis. 19:158–164. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ercelep O, Topcu TO, Bayoglu IV, Ekinci AS, Koca S, Kavgaci H, Ozcelik M, Alacacioglu A, Uzunoglu S, Bozkurt O, et al: Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: A study of Anatolian Society of Medical Oncology. Tumour Biol. 37:12033–12038. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Harada K, Mine S, Yamada K, Shigaki H, Oya S, Baba H and Watanabe M: Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: A single-institute retrospective analysis. Dis Esophagus. 29:314–319. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hasebe M, Yoshikawa K, Nishii R, Kawaguchi K, Kamada T and Hamada Y: Usefulness of 11C-methionine-PET for predicting the efficacy of carbon ion radiation therapy for head and neck mucosal malignant melanoma. Int J Oral Maxillofac Surg. 46:1220–1228. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Heinzelmann-Schwarz VA, Nixdorf S, Valadan M, Diczbalis M, Olivier J, Otton G, Fedier A, Hacker NF and Scurry JP: A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker. Int J Mol Med. 33:784–794. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, et al: Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer. 81:36–44. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hughes MC, Wright A, Barbour A, Thomas J, Smithers BM, Green AC and Khosrotehrani K: Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome. Int J Cancer. 133:3000–3007. 2013.PubMed/NCBI | |
|
Jang HS, Kim JH, Park KH, Lee JS, Bae JM, Oh BH, Rha SY, Roh MR and Chung KY: Comparison of melanoma subtypes among Korean patients by morphologic features and ultraviolet exposure. Ann Dermatol. 26:485–490. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kang X, Zeng Y, Liang J, Li J, Ren D, Chai L, Sun Z, Yu S, Wu X, Han W, et al: Aberrations and clinical significance of BRAF in malignant melanoma: A series of 60 cases in Chinese Uyghur. Medicine (Baltimore). 97:e95092018. View Article : Google Scholar : PubMed/NCBI | |
|
Khan MN, Kanumuri VV, Raikundalia MD, Vazquez A, Govindaraj S, Baredes S and Eloy JA: Sinonasal melanoma: Survival and prognostic implications based on site of involvement. Int Forum Allergy Rhinol. 4:151–155. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kirchoff DD, Deutsch GB, Foshag LJ, Lee JH, Sim MS and Faries MB: Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five Decades. Am Surg. 82:1–5. 2016.PubMed/NCBI | |
|
Kirschner AN, Kidd EA, Dewees T and Perkins SM: Treatment approach and outcomes of vaginal melanoma. Int J Gynecol Cancer. 23:1484–1489. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kong Y, Si L, Li Y, Wu X, Xu X, Dai J, Tang H, Ma M, Chi Z, Sheng X, et al: Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors. Clin Cancer Res. 22:1018–1027. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Konuthula N, Khan MN, Parasher A, Del Signore A, Genden EM, Govindaraj S and Iloreta AM: The presentation and outcomes of mucosal melanoma in 695 patients. Int Forum Allergy Rhinol. 7:99–105. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Koto M, Demizu Y, Saitoh JI, Suefuji H, Tsuji H, Okimoto T, Ohno T, Shioyama Y, Takagi R, Nemoto K, et al Japan Carbon-Ion Radiation Oncology Study Group, : Multicenter study of carbon-ion radiation therapy for mucosal melanoma of the head and neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol Biol Phys. 97:1054–1060. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kuk SK, Won CH, Lee WJ, Shin WJ, Yoon HJ, Hong SD, Hong SP and Lee J: Prognostic significance of nestin in primary malignant melanoma of the oral cavity. Melanoma Res. 26:457–463. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lansu J, Klop WM, Heemsbergen W, Navran A, Al-Mamgani A, Langendijk JA, Kaanders JH, Terhaard C, Karakullukcu B and Hamming-Vrieze O: Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy. Head Neck. 40:86–93. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lawaetz M, Birch-Johansen F, Friis S, Eriksen JG, Kiss K, Gade S, Møller-Madsen M, Pourbordbari N and von Buchwald C: Primary mucosal melanoma of the head and neck in Denmark, 1982–2012: Demographic and clinical aspects. A retrospective DAHANCA study. Acta Oncol. 55:1001–1008. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lee G, Baek CH, Choi NY and Chung MK: The prognostic role of the surgical approach and adjuvant therapy in operable mucosal melanoma of the head and neck. Clin Exp Otorhinolaryngol. 10:97–103. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lee RJ, Lee SA, Lin T, Lee KK and Christensen RE: Determining the epidemiologic, outcome, and prognostic factors of oral malignant melanoma by using the Surveillance, Epidemiology, and End Results database. J Am Dent Assoc. 148:288–297. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lombardi D, Bottazzoli M, Turri-Zanoni M, Raffetti E, Villaret AB, Morassi ML, Ungari M, Vermi W, Battaglia P, Castelnuovo P, et al: Sinonasal mucosal melanoma: A 12-year experience of 58 cases. Head Neck. 38 (Suppl 1):E1737–E1745. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mücke T, Hölzle F, Kesting MR, Loeffelbein DJ, Robitzky LK, Hohlweg-Majert B, Tannapfel A and Wolff KD: Tumor size and depth in primary malignant melanoma in the oral cavity influences survival. J Oral Maxillofac Surg. 67:1409–1415. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Nakamura Y, Fujisawa Y, Tanaka R, Maruyama H, Ishitsuka Y, Okiyama N, Watanabe R and Fujimoto M: Use of immune checkpoint inhibitors prolonged overall survival in a Japanese population of advanced malignant melanoma patients: Retrospective single institutional study. J Dermatol. 45:1337–1339. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Oba J, Nakahara T, Abe T, Hagihara A, Moroi Y and Furue M: Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: An immunohistochemical study and analysis of prognostic value. J Dermatol Sci. 62:116–123. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pandey M, Mathew A, Iype EM, Sebastian P, Abraham EK and Nair KM: Primary malignant mucosal melanoma of the head and neck region: Pooled analysis of 60 published cases from India and review of literature. Eur J Cancer Prev. 11:3–10. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Pfeil AF, Leiter U, Buettner PG, Eigentler TK, Weide B, Meier F and Garbe C: Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009. Melanoma Res. 21:228–234. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Plavc G, But-Hadžić J, Aničin A, Lanišnik B, Didanović V and Strojan P: Mucosal melanoma of the head and neck: A population-based study from Slovenia, 1985–2013. Radiat Oncol. 11:1372016. View Article : Google Scholar : PubMed/NCBI | |
|
Roh MR, Gupta S, Park KH, Chung KY, Lauss M, Flaherty KT, Jönsson G, Rha SY and Tsao H: Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival. J Invest Dermatol. 136:1002–1011. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Samstein RM, Carvajal RD, Postow MA, Callahan MK, Shoushtari AN, Patel SG, Lee NY and Barker CA: Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response. Head Neck. 38:1310–1317. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sanchez A, Rodríguez D, Allard CB, Bechis SK, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, et al: Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol. 34:166.e7–166.e14. 2016. View Article : Google Scholar | |
|
Schaefer T, Satzger I and Gutzmer R: Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients. Medicine (Baltimore). 96:e57532017. View Article : Google Scholar : PubMed/NCBI | |
|
Schmidt MQ, David J, Yoshida EJ, Scher K, Mita A, Shiao SL, Ho AS and Zumsteg ZS: Predictors of survival in head and neck mucosal melanoma. Oral Oncol. 73:36–42. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shoushtari AN, Bluth MJ, Goldman DA, Bitas C, Lefkowitz RA, Postow MA, Munhoz RR, Buchar G, Hester RH, Romero JA, et al: Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma. Melanoma Res. 27:57–64. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shuman AG, Light E, Olsen SH, Pynnonen MA, Taylor JM, Johnson TM and Bradford CR: Mucosal melanoma of the head and neck: Predictors of prognosis. Arch Otolaryngol Head Neck Surg. 137:331–337. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Song H, Jing G, Wang L, Guo W and Ren G: Periodic acid-Schiff-positive loops and networks as a prognostic factor in oral mucosal melanoma. Melanoma Res. 26:145–152. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sun CZ, Li QL, Hu ZD, Jiang YE, Song M and Yang AK: Treatment and prognosis in sinonasal mucosal melanoma: A retrospective analysis of 65 patients from a single cancer center. Head Neck. 36:675–681. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tchelebi L, Guirguis A and Ashamalla H: Rectal melanoma: Epidemiology, prognosis, and role of adjuvant radiation therapy. J Cancer Res Clin Oncol. 142:2569–2575. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Thariat J, Poissonnet G, Marcy PY, Lattes L, Butori C, Guevara N, Dassonville O, Santini J, Bensadoun RJ and Castillo L: Effect of surgical modality and hypofractionated split-course radiotherapy on local control and survival from sinonasal mucosal melanoma. Clin Oncol (R Coll Radiol). 23:579–586. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Wen W, Wu H, Chen Y, Ren G and Guo W: Heparanase expression correlates with poor survival in oral mucosal melanoma. Med Oncol. 30:6332013. View Article : Google Scholar : PubMed/NCBI | |
|
Wen X, Ding Y, Li J, Zhao J, Peng R, Li D, Zhu B, Wang Y and Zhang X and Zhang X: The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: A retrospective case series. Cancer Immunol Immunother. 66:1153–1162. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Won TB, Choi KY, Rhee CS, Jin HR, Yi JS, Dhong HJ, Kim SW, Choi JH, Kim JK, Chung YJ, et al: Treatment outcomes of sinonasal malignant melanoma: A Korean multicenter study. Int Forum Allergy Rhinol. 5:950–959. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yeh JJ, Shia J, Hwu WJ, Busam KJ, Paty PB, Guillem JG, Coit DG, Wong WD and Weiser MR: The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 244:1012–1017. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yi JH, Yi SY, Lee HR, Lee SI, Lim DH, Kim JH, Park KW and Lee J: Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: Multicenter, retrospective analysis in Asia. Melanoma Res. 21:223–227. 2011. View Article : Google Scholar : PubMed/NCBI |
